Who are the key players in the Crysvita Market Report 2026 market?

Major companies operating in the Crysvita Market Report 2026 market are Major companies operating in the crysvita market are Kyowa Kirin Co. Ltd., Ultragenyx Pharmaceutical Inc. Read More

What are the major opportunities in the Crysvita market? What are the strategies for the Crysvita market?

For detailed insights on the major opportunities and strategies in the Crysvita market, Read More

How does the Crysvita market relate to the overall economy and other similar markets?

For detailed insights on Crysvita's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Crysvita market growth? SWOT analysis of the Crysvita market.

For detailed insights on the key dynamics influencing the Crysvita market growth and SWOT analysis of the Crysvita industry, Read More

Crysvita Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Crysvita Market Report 2026

Name: Crysvita Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Crysvita Market Overview

• The Crysvita market growth in the historic period has been driven by limited treatment options for xlh, orphan drug approvals

• Market expansion is supported by growth in rare disease screening, expansion of adult xlh treatment

• Growth Driver: Rise Of Personalized Medicine Fueling Growth In The Market

• Market Trend: Advancements In Prefilled And Patient-Friendly Formulations Enhancing Treatment Convenience And Accessibility

• North America was the largest region in 2025.

What Is Covered Under Crysvita Market?

Crysvita is a prescription medication used to treat X-linked hypophosphatemia (XLH), a rare genetic disorder that leads to low levels of phosphate in the blood, resulting in weak bones, bone pain, and other skeletal issues.

The main types of crysvita are 10 mg, 20 mg, and 30 mg. CysVita 10 mg is a pharmaceutical product that typically contains cysteine as its active ingredient, often in the form of a cysteine-based supplement. These are used for various patient demographics such as pediatric, and adult. The various disease prevalences include x-linked hypophosphatemia, and tumor-induced osteomalacia and are used for various applications such as hospitals, clinics, and others.

Crysvita Market Global Report 2026 Market Report bar graph

What Is The Crysvita Market Size and Share 2026?

The growth in the historic period can be attributed to limited treatment options for xlh, orphan drug approvals, improved rare disease diagnosis, specialist center adoption, patient advocacy initiatives.

What Is The Crysvita Market Growth Forecast?

The growth in the forecast period can be attributed to growth in rare disease screening, expansion of adult xlh treatment, increased biologic orphan drug investment, broader reimbursement access, improved long term clinical outcomes. Major trends in the forecast period include rising adoption of targeted therapies for rare diseases, growth of precision medicine in genetic disorders, expansion of pediatric rare disease treatments, increased awareness of x linked hypophosphatemia, shift toward long term disease management.

Book your 30 minutes free consultation with our research experts

Global Crysvita Market Segmentation

1) By Type: 10 mg, 20 mg, 30 mg

2) By Patient Demographics: Pediatric, Adult

3) By Disease Prevalence: X-Linked Hypophosphatemia, Tumor-Induced Osteomalacia

4) By Application: Hospitals, Clinics, Other Applications

What Is The Driver Of The Crysvita Market?

Rising personalized medicine is expected to propel the growth of the Crysvita market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare strategies to the individual characteristics of each patient, such as their genetic makeup, environment, and lifestyle, to achieve the most effective and precise outcomes. Advances in genomic technologies and better understanding of diseases allow for the development of targeted therapies tailored to individual genetic profiles. This combination is driving the rise of personalized medicine, improving treatment effectiveness and patient outcomes. Crysvita exemplifies personalized medicine by offering targeted treatment for X-linked hypophosphatemia (XLH), addressing the unique genetic and metabolic needs of individual patients to improve bone health and quality of life. For instance, in February 2024, according to a report published by the Personalized Medicine Coalition, a US-based organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, rising personalized medicine drives the crysvita industry.

Key Players In The Global Crysvita Market

Major companies operating in the crysvita market are Kyowa Kirin Co. Ltd., Ultragenyx Pharmaceutical Inc.

Global Crysvita Market Trends and Insights

Major companies operating in the crysvita market are focusing on developing more patient-friendly and prefilled formulations and improving treatment convenience to enhance therapeutic accessibility and outcomes. For instance, in June 2025, Kyowa Kirin Co Ltd., a Japan-based pharmaceytical company, has received approval in Japan for a new prefilled syringe formulation of Crysvita, offering a more convenient and safer alternative to the existing vial version. Originally approved in 2019 and later enabled for self-injection in 2020, Crysvita treats FGF23-related hypophosphatemic conditions such as XLH and TIO. The new syringe format simplifies administration, reduces preparation steps, and eases the burden on patients, families, and healthcare professionals. As the only therapy that directly targets FGF23, Crysvita® continues to play a key role in managing phosphate-regulating disorders. This launch reflects Kyowa Kirin’s ongoing commitment to advancing patient-friendly treatment options.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Crysvita Market?

In November 2025, OMERS Life Sciences, a Canada-based life sciences-focused investment capital company, acquired a 25% royalty interest in future North American sales of Crysvita from Ultragenyx for $400 million. With this acquisition, OMERS aims to strengthen its portfolio returns by expanding exposure to a high-growth rare-disease therapy with a proven commercial track record. The acquired royalty interest originates from Ultragenyx, a US-based biopharmaceutical company that specializes in innovative treatments for serious rare and ultra-rare genetic diseases.

Regional Insights

North America was the largest region in the crysvita market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Crysvita Market?

The crysvita market consists of sales of injection and drug formulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Crysvita Market Report 2026?

The crysvita market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the crysvita industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Crysvita Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Patient Demographics, Disease Prevalence, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Kyowa Kirin Co. Ltd., Ultragenyx Pharmaceutical Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Crysvita Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Crysvita Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Crysvita Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Crysvita Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted Therapies For Rare Diseases

4.2.2 Growth Of Precision Medicine In Genetic Disorders

4.2.3 Expansion Of Pediatric Rare Disease Treatments

4.2.4 Increased Awareness Of X Linked Hypophosphatemia

4.2.5 Shift Toward Long Term Disease Management

5. Crysvita Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Rare Disease Treatment Centers

5.4 Pediatric Clinics

5.5 Endocrinology Centers

6. Crysvita Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Crysvita Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Crysvita PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Crysvita Market Size, Comparisons And Growth Rate Analysis

7.3. Global Crysvita Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Crysvita Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Crysvita Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Crysvita Market Segmentation

9.1. Global Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10 mg, 20 mg, 30 mg

9.2. Global Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult

9.3. Global Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

X-Linked Hypophosphatemia, Tumor-Induced Osteomalacia

9.4. Global Crysvita Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Other Applications

10. Crysvita Market Regional And Country Analysis

10.1. Global Crysvita Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Crysvita Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Crysvita Market

11.1. Asia-Pacific Crysvita Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Crysvita Market

12.1. China Crysvita Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Crysvita Market

13.1. India Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Crysvita Market

14.1. Japan Crysvita Market Overview

14.2. Japan Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Crysvita Market

15.1. Australia Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Crysvita Market

16.1. South Korea Crysvita Market Overview

16.2. South Korea Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Crysvita Market

17.1. Western Europe Crysvita Market Overview

17.2. Western Europe Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Crysvita Market

18.1. UK Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Crysvita Market

19.1. Germany Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Crysvita Market

20.1. France Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Crysvita Market

21.1. Eastern Europe Crysvita Market Overview

21.2. Eastern Europe Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Crysvita Market

22.1. North America Crysvita Market Overview

22.2. North America Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Crysvita Market

23.1. USA Crysvita Market Overview

23.2. USA Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Crysvita Market

24.1. Canada Crysvita Market Overview

24.2. Canada Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Crysvita Market

25.1. South America Crysvita Market Overview

25.2. South America Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Crysvita Market

26.1. Middle East Crysvita Market Overview

26.2. Middle East Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Crysvita Market

27.1. Africa Crysvita Market Overview

27.2. Africa Crysvita Market, Segmentation By Type, Segmentation By Patient Demographics, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Crysvita Market Regulatory and Investment Landscape

29. Crysvita Market Competitive Landscape And Company Profiles

29.1. Crysvita Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Crysvita Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Crysvita Market Company Profiles

29.3.1. Kyowa Kirin Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

29.3.2. Ultragenyx Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Crysvita Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Crysvita Market

32. Crysvita Market High Potential Countries, Segments and Strategies

32.1 Crysvita Market In 2030 - Countries Offering Most New Opportunities

32.2 Crysvita Market In 2030 - Segments Offering Most New Opportunities

32.3 Crysvita Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Crysvita Market, Overview Of Key Products - Product Examples

Table 2: Global Crysvita Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Crysvita Market, Supply Chain Analysis

Table 4: Global Crysvita Market, Major Raw Material Providers

Table 5: Global Crysvita Market, Major Resource Providers

Table 6: Global Crysvita Market, Major Manufacturers (Suppliers)

Table 7: Global Crysvita Market, Major Distributors And Channel Partners

Table 8: Global Crysvita Market, Key Technologies & Future Trends

Table 9: Global Crysvita Market, Major Trends

Table 10: Global Crysvita Market, Major End Users

Table 11: Global Crysvita Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Crysvita Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Crysvita Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Crysvita Market - TAM, US$ Billion, 2025

Table 15: Global Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Crysvita Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Crysvita Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Crysvita Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: South Korea, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Western Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: UK, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Germany, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: France, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Eastern Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: North America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: USA, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Canada, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: South America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Middle East, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Africa, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Global Crysvita Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 73: Global Crysvita Market - Company Scoring Matrix

Table 74: Kyowa Kirin Co. Ltd. Financial Performance

Table 75: Ultragenyx Pharmaceutical Inc. Financial Performance

Table 76: Global Crysvita Market, Competitive Benchmarking (In USD Billions)

Table 77: Global Crysvita Market, Competitive Dashboard

Table 78: Global Crysvita Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 79: Global, Crysvita Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 80: Global, Crysvita Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Table 81: Global, Crysvita Market Size Gain ($ Billion), Segmentation By Disease Prevalence, 2025 – 2030

List Of Figures

Figure 1: Global Crysvita Market, Overview Of Key Products - Product Examples

Figure 2: Global Crysvita Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Crysvita Market, Supply Chain Analysis

Figure 4: Global Crysvita Market, Major Raw Material Providers

Figure 5: Global Crysvita Market, Major Resource Providers

Figure 6: Global Crysvita Market, Major Manufacturers (Suppliers)

Figure 7: Global Crysvita Market, Major Distributors And Channel Partners

Figure 8: Global Crysvita Market, Key Technologies & Future Trends

Figure 9: Global Crysvita Market, Major Trends

Figure 10: Global Crysvita Market, Major End Users

Figure 11: Global Crysvita Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Crysvita Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Crysvita Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Crysvita Market - TAM, US$ Billion, 2025

Figure 15: Global Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Crysvita Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Crysvita Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Crysvita Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: South Korea, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Western Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: UK, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Germany, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: France, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Eastern Europe, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: North America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: USA, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Canada, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: South America, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Middle East, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Crysvita Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Crysvita Market, Segmentation By Patient Demographics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Africa, Crysvita Market, Segmentation By Disease Prevalence, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Global Crysvita Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 73: Global Crysvita Market - Company Scoring Matrix

Figure 74: Kyowa Kirin Co. Ltd. Financial Performance

Figure 75: Ultragenyx Pharmaceutical Inc. Financial Performance

Figure 76: Global Crysvita Market, Competitive Benchmarking (In USD Billions)

Figure 77: Global Crysvita Market, Competitive Dashboard

Figure 78: Global Crysvita Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 79: Global, Crysvita Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 80: Global, Crysvita Market Size Gain ($ Billion), Segmentation By Patient Demographics, 2025 – 2030

Figure 81: Global, Crysvita Market Size Gain ($ Billion), Segmentation By Disease Prevalence, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Cryogenic Insulation Market Report 2026 - Global Outlook – By Type (Cellular, Fibrous, Flake, Granular, Reflective, Other Types), By Application (Storage Tanks, Fuel Tanks, Pipe Systems, Terminals, Other Applications), B...

Cryochambers Market Report 2026 - Global Outlook – By Type (Individual Units Or Cryosauna, Multiple Person Units Or Cryochambers), By Therapy (Cryosurgery, Icepack Therapy, Chamber Therapy), By Application (Fitness Cente...

Cryoablation Devices Market Report 2026 - Global Outlook – By Type (Probe, Tissue Contact Probe Ablators, Epidermal And Subcutaneous Cryoablation Systems, Systems, Generator, Accessories And consumables), By Application ...

Cryocooler Market Report 2026 - Global Outlook – By Offering (Hardware, Services), By Type (Pulse-Tube (PT), Gifford-McMohan (GM), Joule-Thomson (JT), Brayton, Stirling), By Operating Cycle (Open-Loop Cycle, Closed-Loop ...

Cryotherapy Market Report 2026 - Global Outlook – By Therapy Type (Cryosurgery, Icepack Therapy, Chamber Therapy), By Device (Cryosurgery Device, Localized Cryotherapy Device, Cryochambers And Cryosaunas, Cryogun), By Ap...

Cryogenic Pump Market Report 2026 - Global Outlook – By Type (Positive Displacement Pump, Centrifugal Pump), By Cryogen Type (Nitrogen, Oxygen, Argon, Liquefied Natural Gas, Other Cryogen Type), By Orientation (Horizonta...

Cryogenic Transportation Services Market Report 2026 - Global Outlook – By Type (Trailer Transportation; Truck Transportation), By Cryogen Type (Nitrogen; Oxygen; Natural Gas; Argon; Other Cryogen Types), By Application ...

Frequently Asked Questions

How big is the Crysvita Market?

The Crysvita market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Crysvita market growth?

The global Crysvita market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Crysvita market?

Some Key Players in the Crysvita market Include, Kyowa Kirin Co. Ltd., Ultragenyx Pharmaceutical Inc. .

What is the anticipated growth trend for the Crysvita market?

Major trend in this market includes: Advancements In Prefilled And Patient-Friendly Formulations Enhancing Treatment Convenience And Accessibility. For further insights on this market. request a sample here

Which region has the most growth potential in the Crysvita market?

North America was the largest region in the crysvita market in 2025. The regions covered in the crysvita market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.